Skip to main content
. Author manuscript; available in PMC: 2011 Aug 8.
Published in final edited form as: Psychopharmacology (Berl). 2010 Apr 24;210(4):453–469. doi: 10.1007/s00213-010-1848-1

Table 4.

Studies contributing effect size data for the meta-analysis of alerting attention-response time

Study Task/outcome Hedges’s g Standard error n Agea % male Smoking status Cigarettes per daya Nicotine dose, mg Route of administration
Barr et al. 2008b Signal detection 0.38 0.19 30 39 53 NSm NA 14 Transdermal
Bates et al. 1995 Choice RT 0.47 0.23 19 21 32 Sm 5–25 0.8 Inhalation-cigarette
File et al. 2001 RVIP 0.37 0.35 32 21 50 NSm NA 2 Inhalation-inhaler
Foulds et al. 1996b RVIP 1.42 0.33 18 25 50 NSm NA 0.6 Subcutaneous
Kelemen and Fulton 2008 RVIP 0.28 0.18 32 24 69 Sm >10 2 Buccal
Kleykamp et al. 2005b ANT −0.16 0.22 20 20 45 NSm NA 4 Buccal
Lawrence et al. 2002 RVIP 0.07 0.24 15 22 53 Sm 22 21 Transdermal
Le Houezec et al. 1994 Choice RT 0.50 0.29 12 27 100 NSm NA 0.8 Subcutaneous
Levin et al. 1998 CPT 0.10 0.28 11 23 91 NSm NA 7 Transdermal
Myers et al. 2008b CPT 0.27 0.20 25 36 52 Sm 22 2 Intranasal
Poltavski and Petros 2006 CPT 0.38 0.36 30 20 100 NSm NA 7 Transdermal
Rusted and Alvares 2008 RVIP 0.64 0.29 48 22 44 NSm NA 1 Intranasal
Thiel et al. 2005b Cued target detection 0.27 0.22 19 24 42 NSm NA 2 Buccal

Nsm nonsmoker, Sm smoker, NA not applicable, RVIP rapid visual information processing, ANT attention network test, CPT continuous performance test

a

Mean value

b

Administered multiple active nicotine doses